CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,355,000 | +122.4% | 1,010,601 | +171.1% | 0.00% | +200.0% |
| Q4 2017 | $1,059,000 | +28.2% | 372,815 | +29.0% | 0.00% | 0.0% |
| Q3 2017 | $826,000 | +16.0% | 288,905 | +0.3% | 0.00% | 0.0% |
| Q2 2017 | $712,000 | +12.8% | 288,073 | +64.9% | 0.00% | 0.0% |
| Q1 2017 | $631,000 | +6.4% | 174,705 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $593,000 | -11.6% | 167,582 | +0.9% | 0.00% | 0.0% |
| Q3 2016 | $671,000 | -7.3% | 166,149 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $724,000 | +20.7% | 164,942 | +3.9% | 0.00% | 0.0% |
| Q1 2016 | $600,000 | -90.9% | 158,794 | -62.3% | 0.00% | -91.7% |
| Q4 2015 | $6,613,000 | +79.7% | 421,746 | +20.8% | 0.01% | +71.4% |
| Q3 2015 | $3,680,000 | -58.1% | 349,140 | +0.3% | 0.01% | -56.2% |
| Q2 2015 | $8,780,000 | -9.0% | 348,135 | +0.5% | 0.02% | -11.1% |
| Q1 2015 | $9,651,000 | +153.2% | 346,301 | +65.8% | 0.02% | +157.1% |
| Q4 2014 | $3,812,000 | +40.8% | 208,890 | 0.0% | 0.01% | +40.0% |
| Q3 2014 | $2,707,000 | -20.4% | 208,890 | +0.2% | 0.01% | -28.6% |
| Q2 2014 | $3,402,000 | -9.3% | 208,470 | -1.8% | 0.01% | -12.5% |
| Q1 2014 | $3,749,000 | -26.3% | 212,195 | +1.0% | 0.01% | -27.3% |
| Q4 2013 | $5,088,000 | +29.9% | 210,148 | +90.0% | 0.01% | +10.0% |
| Q3 2013 | $3,918,000 | +134.6% | 110,578 | +3.4% | 0.01% | +150.0% |
| Q2 2013 | $1,670,000 | – | 106,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |